Stay updated on Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision number updated from v3.6.5 to v3.6.6, signaling a new page revision. This likely reflects minor updates to the study record or related documentation.
    Difference
    0.0%
    Check dated 2026-08-29T23:35:33.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The revision label changed from v3.6.4 to v3.6.5, representing an update to the page's revision metadata. This change does not affect the study content or how the page functions.
    Difference
    0.0%
    Check dated 2026-08-08T17:08:22.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision: v3.6.4 was added and replaces the previous v3.6.3, indicating a small update to the page's versioning.
    Difference
    0.0%
    Check dated 2026-07-25T08:30:12.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.2 to v3.6.3, reflecting a minor version update to the document.
    Difference
    0.0%
    Check dated 2026-07-03T22:37:55.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Adds a new Revision: v3.6.2 label and removes the previous Revision: v3.6.0 label, updating the page's revision metadata to reflect the latest version. This change is related to internal versioning and does not alter the page's content or functionality.
    Difference
    0.0%
    Check dated 2026-06-26T19:43:36.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    The page now shows that recruitment has ended for this study, while new navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) were added. The Intervention/Treatment label formatting appears to have been adjusted as part of the revision.
    Difference
    0.1%
    Check dated 2026-06-12T11:51:26.000Z thumbnail image

Stay in the know with updates to Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.